Literature DB >> 18595696

Activation of CFTR by UCCF-029 and genistein.

Layla Al-Nakkash1, Mark F Springsteel, Mark J Kurth, Michael H Nantz.   

Abstract

The mechanism of action of a novel CFTR activator UC(CF)-029 on NIH3T3 cells stably expressing DeltaF508-CFTR was investigated and its effects compared to those of genistein, a known CFTR activator. This study shows that UC(CF)-029 and genistein have differing efficacies. The efficacy of UC(CF)-029 in the presence of forskolin (10microM) is approximately 50% that of genistein; however, the EC(50)'s for both drugs are comparable; 3.5microM for UC(CF)-029 and 4.4muM for genistein. Using NIH3T3 cells stably transfected with K1250A-CFTR we find that CFTR channel open time is unaffected by UC(CF)-029 or genistein, supporting the hypothesis that these compounds stabilize the open state by inhibiting ATP hydrolysis at NBD2. Our data suggest that the ability of UC(CF)-029 to augment DeltaF508-CFTR channel activity necessitates further interest.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18595696     DOI: 10.1016/j.bmcl.2008.06.051

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  4 in total

Review 1.  Curcumin and genistein: the combined effects on disease-associated CFTR mutants and their clinical implications.

Authors:  Yoshiro Sohma; Ying-Chun Yu; Tzyh-Chang Hwang
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

2.  Natural Compounds as Therapeutic Agents in the Treatment Cystic Fibrosis.

Authors:  Isha Dey; Kalpit Shah; Neil A Bradbury
Journal:  J Genet Syndr Gene Ther       Date:  2016-01-30

Review 3.  Estrogen and estrogen receptors in the modulation of gastrointestinal epithelial secretion.

Authors:  Xin Yang; Yanjun Guo; Jialin He; Fenglian Zhang; Xuemei Sun; Shiming Yang; Hui Dong
Journal:  Oncotarget       Date:  2017-05-31

4.  Genistein Activates Transcription Factor EB and Corrects Niemann-Pick C Phenotype.

Authors:  Graciela Argüello; Elisa Balboa; Pablo J Tapia; Juan Castro; María José Yañez; Pamela Mattar; Rodrigo Pulgar; Silvana Zanlungo
Journal:  Int J Mol Sci       Date:  2021-04-19       Impact factor: 5.923

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.